Yocell Biotechnology (Qingdao) Co., LTD

Carbon nanotubes (CNTs), seamless tubular nanomaterials formed by rolling single or multiple layers of graphene sheets, have caused a sensation in the materials science community since their official discovery by Professor Sumio Ijima in 1991, thanks to their extraordinary mechanical, electrical, thermal and chemical properties. Its huge specific surface area and unique nano-scale hollow structure have enabled it to demonstrate remarkable application potential in numerous cutting-edge fields.

The Yocell NexTract025 protein purification system has been officially launched in the biological laboratory of Moscow State University. This system, with its outstanding performance, meets the demanding requirements of the university's cutting-edge biological research, and will provide stable and efficient support for the purification of key biological molecules such as antibodies and recombinant proteins.

In the biopharmaceutical field, traditional mammalian cell culture has long dominated, but it faces challenges such as high costs and long cycles. Chapter 8 "Production of Complex Proteins in Plants: From Farming to Manufacturing" in Biopharmaceutical Manufacturing: Progress, Trends and Challenges reveals a brand-new "green production pathway" — plant cell culture technology. With its unique advantages, it has emerged as a promising candidate for complex protein production.

Designed for dairy products, sauces and health foods, this machine is the key to improving the efficiency of food production by significantly improving texture, stability and taste. This experienced food processor trusts our quality and service based on repeat customer recommendations.

Antibody-conjugated drugs (ADCs) are novel tumor treatment drugs that possess both precise targeting and efficient killing capabilities. With advantages such as enhanced efficacy and reduced systemic toxicity, they have become a research hotspot. The tangential flow filtration (TFF) technology is widely used in the downstream process of ADC drugs, capable of efficiently removing organic impurities, coupling related impurities, and achieving buffer solution replacement. The ADC recovery rate exceeds 90%. This technology requires optimizing the process by controlling key parameters such as inlet and outlet pressure, flow rate, and pH. The core application lies in antibody concentration and desalination, product purification, and buffer solution replacement of ADC drugs, providing core support for the efficient preparation and stability of ADC drugs. Yocell's tangential flow system, through technological innovation, helps advance anti-tumor treatment towards precision and reliability.

The annual global pharmaceutical industry event "Pharmtech & Ingredients" will be grandly launched in Moscow from November 25th to 28th, 2025. At that time, we will make a stunning appearance with our GMP-level fermenter system.